Open-Label Hepatic Impairment Study

Summary

This study will be conducted in Hepatitis C positive patients to determine whether the pharmacodynamic effects of PSI-7977 or PSI-352938 are similar to HCV-infected patients with normal hepatic function, which may allow inclusion of patients with cirrhosis and varying degrees of hepatic dysfunction in future clinical studies.

Timeline

Start

2011-07

Primary completion

2012-01

Completion

2012-01

Drugs

Indications